Based on these data, we propose that controlling the rates of 5-HT uptake may represent a novel approach to alleviating sepsis-associated microvascular dysfunction and leakage by taking advantage of the endogenous SERT uptake mechanism already in place. The gene discussed is SLC6A4; the disease is Sepsis.